HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaharu Hazawa Selected Research

Nuclear Pore Complex Proteins (Nucleoporins)

1/2022Discovery of a Novel Aminocyclopropenone Compound That Inhibits BRD4-Driven Nucleoporin NUP210 Expression and Attenuates Colorectal Cancer Growth.
1/2021Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma.
1/2017High-Speed Atomic Force Microscopy Reveals Loss of Nuclear Pore Resilience as a Dying Code in Colorectal Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaharu Hazawa Research Topics

Disease

17Neoplasms (Cancer)
01/2022 - 04/2009
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 01/2012
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 03/2018
2Squamous Cell Carcinoma of Head and Neck
04/2020 - 01/2020
2Human Influenza (Influenza)
01/2020 - 01/2020
2Leukemia
11/2017 - 04/2011
2Glioma (Gliomas)
05/2015 - 12/2007
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2012 - 10/2011
1Ependymoma
01/2021
1Esophageal Squamous Cell Carcinoma
10/2020
1Colonic Neoplasms (Colon Cancer)
10/2020
1Rupture
01/2020
1Adenoma (Adenomas)
01/2020
1Influenza in Birds (Avian Flu)
01/2020
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2018
1Carcinogenesis
01/2018
1Multiple Organ Failure (MODS)
12/2016
1Parkinsonian Disorders (Parkinsonism)
05/2015
1Measles
07/2014
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2013
1Radiation Injuries (Radiation Sickness)
01/2012
1Polyploidy
01/2012
1Lymphoid Leukemia
04/2011
1Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2011
1Carcinoma (Carcinomatosis)
01/2011

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2012
5AlkaloidsIBA
08/2012 - 12/2007
3Nuclear Pore Complex Proteins (Nucleoporins)IBA
01/2022 - 01/2017
3Biological ProductsIBA
01/2022 - 04/2011
2Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2021
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2018
2Hemagglutinins (Hemagglutinin)IBA
01/2020 - 01/2020
2Virulence Factors (Pathogenicity Factors)IBA
01/2020 - 01/2020
2DiterpenesIBA
08/2012 - 01/2011
1Pharmaceutical PreparationsIBA
01/2022
1Beclin-1IBA
01/2021
1Sirolimus (Rapamycin)FDA Link
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA
01/2021
1Bovine Serum AlbuminIBA
01/2021
1Lamin Type B (Lamin B)IBA
01/2021
1Chloroquine (Aralen)FDA LinkGeneric
01/2021
1ChromatinIBA
01/2021
1Mitogen-Activated Protein Kinase 8IBA
01/2021
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2021
1Phosphates (Orthophosphate)IBA
01/2021
1Heat Shock Transcription FactorsIBA
01/2021
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2021
1Qa-SNARE Proteins (Syntaxin)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Autophagy-Related Protein-1 HomologIBA
01/2021
1ARV-771IBA
10/2020
11,2-cyclohexanediolIBA
10/2020
1romidepsin (FK228)FDA Link
10/2020
1importazoleIBA
04/2020
1B7-H1 AntigenIBA
04/2020
13- (4- methylphenylsulfonyl)- 2- propenenitrileIBA
01/2020
1Karyopherins (Importin)IBA
01/2020
1Peptides (Polypeptides)IBA
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020
1trametinibIBA
01/2020
1Interleukin-23 (Interleukin 23)IBA
01/2020
1BuffersIBA
01/2020
1Glycogen Synthase KinasesIBA
03/2018
1Glycogen Synthase (Synthase I)IBA
03/2018
1Dyneins (Dynein)IBA
03/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2018
1Protein Isoforms (Isoforms)IBA
01/2018
1Small Interfering RNA (siRNA)IBA
01/2018
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2018
1Sirtuin 2IBA
01/2018
1Sirtuin 3IBA
01/2018
1Ataxia Telangiectasia Mutated ProteinsIBA
01/2018
1MLN 8237IBA
01/2017
1Plasminogen Activators (Plasminogen Activator)IBA
12/2016
1CateninsIBA
05/2015
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
05/2015
1AntibodiesIBA
07/2014
1Keratan SulfateIBA
01/2013
1Proteoglycans (Proteoglycan)IBA
01/2013
1CaspasesIBA
06/2012
1homoserine lactoneIBA
02/2012
1Radiation-Sensitizing AgentsIBA
01/2012
1VitronectinIBA
01/2012
1Acyl-ButyrolactonesIBA
01/2012
1pyrazolanthroneIBA
01/2012
1JNK Mitogen-Activated Protein KinasesIBA
01/2012
1AcridinesIBA
01/2012
1Hydroxyl RadicalIBA
08/2011
1Laminin ReceptorsIBA
04/2011

Therapy/Procedure

1Therapeutics
01/2021
1Injections
10/2020